Update on Cardiac Tumors – review (RCD code: VI)

Journal Title: Journal of Rare Cardiovascular Diseases - Year 2014, Vol 1, Issue 8

Abstract

The prevalence of cardiac tumors is 0.021% (1 person in 5000). These data are based on a meta-analysis of pathological studies from the early decades of the twentieth century. It is likely that nowadays the incidence of cardiac tumors and primary tumors of the heart is greater. The cardiac tumors are very rare and histologically heterogeneous. These leads to, the lack of established diagnostic schemes, that would allow to distinguish cardiac tumors from metastatic tumors, intracardiac thrombus, vegetations on the valves in infective endocarditis or in the process of connective tissue diseases or thrombotic changes of the valves in the process of metastatic disease (called endocarditis marantica). Cardiac tumors may be symptomatic or found incidentally during evaluation for a seemingly unrelated problem or physical finding. In symptomatic patients, a mass can virtually always be detected by echocardiography, magnetic resonance imaging (MRI), and/or computed tomography (CT). Because symptoms may mimic other cardiac conditions, the clinical challenge is to consider the possibility of a cardiac tumor so that the appropriate diagnostic tests can be conducted. There are very few studies, assessing the results of cardiac surgery in the individual centers. There is also lack of set of standards in the chemotherapy of malignant cardiac tumors. Moreover its routine use is sometimes discussed. JRCD 2014; 1 (8): 5–10

Authors and Affiliations

Monika Komar, Giovanni La Canna, Ula Gancarczyk, Paweł Prochownik, Hanna Dziedzic‑Oleksy, Piotr Podolec

Keywords

Related Articles

Long term follow-up after the Ross procedure (RCD code: IV-5A.O)

Aims: The aim of this study was to analyze the incidence of long-term complications observed during follow-up of patients who had undergone the Ross procedure in childhood. Methods: The study engaged a cohort of 9 patien...

Clinical Classification of Rare Cardiovascular Diseases and Disorders

Rare diseases and disorders constitute important clinical problems. There are many concerns among physicians while planning the diagnostic and treatment process of such a heterogenous group of patients. These concerns ar...

Long‑term experience in patients undergoing endovascular revascularization procedures for symptomatic Takayasu arteritis (RCD code: I-3A.1)

Takayasu arteritis (TA) is often manifested by a prolonged limb claudication, renovascular hypertension or a sudden ischemic stroke (IS) or myocardial infarction (MI) occurring in young adults. The study aimed to assess...

Introduction

Introduction

Pulmonary arterial hypertension: management in specific medical conditions

Pulmonary arterial hypertension (PAH) is a severe and progressive disease. Due to the narrowing of the blood vessels in the lungs, pul- monary vascular resistance and pulmonary pressures increase. This results in reduced...

Download PDF file
  • EP ID EP245410
  • DOI 10.20418/jrcd.vol1no8.158
  • Views 98
  • Downloads 0

How To Cite

Monika Komar, Giovanni La Canna, Ula Gancarczyk, Paweł Prochownik, Hanna Dziedzic‑Oleksy, Piotr Podolec (2014). Update on Cardiac Tumors – review (RCD code: VI). Journal of Rare Cardiovascular Diseases, 1(8), 5-10. https://europub.co.uk/articles/-A-245410